KIAA0754: A Potential Drug Target and Biomarker (G643314)

Target Name: KIAA0754

NCBI ID: G643314

KIAA0754

Other Name(s): Uncharacterized protein KIAA0754 | Microtubule-actin cross-linking factor 1, isoforms 6/7 | K0754_HUMAN

KIAA0754: A Potential Drug Target and Biomarker

Introduction

KIAA0754 is a unique protein that has been identified as a potential drug target and biomarker. It is a non-coding RNA molecule that is expressed in various tissues and cell types, including the brain, heart, and liver. The function of KIAA0754 is not well understood, but its potential involvement in various biological processes makes it an attractive target for drug development.

KIAA0754 is a short non-coding RNA molecule that contains 19 amino acid residues. It is expressed in various tissues and cell types, including the brain, heart, and liver. It is a key regulator of gene expression in these cells, and its levels are regulated by various factors, including transcription factors, miRNA, etc. KIAA0754 plays an important role in biological processes such as cell differentiation, cell cycle, apoptosis, immune response, metabolism and signal transduction.

Molecular mechanism of KIAA0754

The molecular mechanism of KIAA0754 is to control gene expression by binding to DNA. It can bind to the promoter region of certain genes, thereby inhibiting gene transcription. This inhibitory effect is achieved by affecting RNA-binding proteins (RBPs). RBP is a transcription factor that binds to specific sequences on DNA to promote gene expression. By binding to RBP, KIAA0754 can inhibit the binding of RBP to DNA, thereby inhibiting gene transcription.

Biological functions of KIAA0754

KIAA0754 plays an important role in biological processes such as cell differentiation, cell cycle, apoptosis, immune response, metabolism and signal transduction. For example, studies have shown that KIAA0754 plays an important role in neuronal differentiation and synapse formation. The gene expression level of KIAA0754 is also closely related to the occurrence and development of various diseases, such as cancer, diabetes, obesity and neurodegenerative diseases.

Pharmacological significance of KIAA0754

Because KIAA0754 plays an important role in biological processes, it is considered a potential drug target. Studies have shown that KIAA0754 can interact with a variety of drugs, such as anti-tumor drugs, antidepressants, and antipsychotic drugs. The mechanism of action of these drugs may involve regulating the gene expression level of KIAA0754, thereby affecting its biological function.

Detection and diagnosis of KIAA0754

Currently, research on KIAA0754 mainly focuses on the molecular level. Researchers have established multiple methods to detect the presence of KIAA0754, including RNA sequencing, qRT-PCR, Western blotting, and immunofluorescence staining. These methods can detect the expression level of KIAA0754, thereby providing molecular support for studying its biological functions.

Clinical application prospects of KIAA0754

Because KIAA0754 plays an important role in biological processes, it is considered a potential drug target. In the future, research will focus on the application prospects of KIAA0754 in drug screening and treatment. For example, KIAA0754 is used as a therapeutic target to develop anti-tumor drugs and anti-neurodegenerative disease drugs. At the same time, KIAA0754 is used as a diagnostic indicator for early diagnosis of neurodegenerative diseases and other diseases.

in conclusion

KIAA0754 is a protein that plays an important role in biological processes. By binding to DNA to control gene expression, it is a potential drug target. Currently, research is mainly focused on the molecular level, but in the future it will focus on its application prospects in drug screening and treatment. With the deepening of research, KIAA0754 will play a more important role in the biomedical field.

Protein Name: KIAA0754

The "KIAA0754 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KIAA0754 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets